Filter Coffee

The Latest

Why is Mankind Pharma betting ₹511 crore on cancer treatment?

Mankind Pharma has acquired a 70% stake in Belgium’s ACTx for ₹511 crore, entering CAR-T cancer therapies and expanding its European presence into biotechnology research.

Coffee Crew | Oct 16, 2026

Newsletter

Editor's Choice

View All

Newsletter

IDBI Bank finds its new owner 💼Coffee Crew | Oct 15, 2026

IPO Explainer

What is Zetwerk really betting on?Coffee Crew | Oct 14, 2026

News

Groww Q2 profit dips despite rising market shareCoffee Crew | Oct 14, 2026

Bite-sized insights for the everyday investor

no spam, no bs ☝️

The Latest

Why is Mankind Pharma betting ₹511 crore on cancer treatment?

Jio’s IPO rings in ₹30,213 crore 📞

What changes SEBI has made in the CAS framework?

Jio IPO: Inside India's Biggest Public Offering

Why is CEAT losing its grip on profits?

Nestlé shares fall as in-line results disappoint investors

Editor's Choice